Bio-Rad Laboratories (BIO) Equity Ratio (2009 - 2026)

Bio-Rad Laboratories (BIO) has 18 years of Equity Ratio data on file, last reported at 0.7 in Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.7, down 96.77% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.7 (down 96.77% YoY), and the FY2025 annual result was 0.7, changed 0.45% from the prior year.
• Equity Ratio retreated to 0.7 in Q1 2026 per BIO's latest filing, from 0.7 in the prior quarter.
• Over five years, Equity Ratio peaked at 29137.33 in Q4 2023 and troughed at 0.69 in Q3 2025.
• A 5-year average of 3014.87 and a median of 0.71 in 2022 frame the typical range for Equity Ratio.
• The sharpest annual moves came in 2022 and 2024: Equity Ratio soared 24221.62% in 2022, then plunged 100.0% in 2024.
• A 5-year view of Equity Ratio shows it stood at 16025.33 in 2022, then soared by 81.82% to 29137.33 in 2023, then sank by 100.0% to 0.7 in 2024, then gained by 0.45% to 0.7 in 2025, then dropped by 0.7% to 0.7 in 2026.
• Business Quant data shows BIO's Equity Ratio at 0.7 in Q1 2026, 0.7 in Q4 2025, and 0.69 in Q3 2025.